483 Wyeth Pharmaceutical Division of Wyeth Holdings Jun 2000

483 Wyeth Pharmaceutical Division of Wyeth Holdings Jun 2000

Susan Laska FDA, James Maclaughlin FDA, Marsha Major FDA, Richard Thornton FDA$119.00 - Available Now

FDA investigators audited the Wyeth Pharmaceutical Division of Wyeth Holdings - Pearl River, NY, United States facility and issued inspectional observations (via FDA 483) on 13 Jun 2000.

Product details

  • Category: Human Drugs / Biologics
  • Inspection end: 13 Jun 2000
  • Location: Pearl River, United States
  • FEI: 2410662
Add To Cart